Navigation Links
UV-C Treatment—a New Procedure for Viral Inactivation, New and Upcoming Webinar Hosted by Xtalks

Toronto, Canada (PRWEB) December 03, 2013

Virus clearance studies are performed to ensure that the purification process has sufficient capability to remove and/or inactivate any viruses that may possibly contaminate the starting material. Selected steps are tested against a panel of viruses, including both enveloped and non-enveloped. It is typically more difficult to show viral clearance for non-enveloped viruses than enveloped viruses because of their smaller size and their relative resistance to physical-chemical inactivation. For these reasons, there is a need for an effective inactivation procedure for non-enveloped viruses.

UV-C treatment has been evaluated in the past for viral inactivation, but recent improvements in the technology have made it practical to use for the first time. Adding this step to a manufacturing process can provide an additional option for viral clearance for products where it is difficult to show adequate clearance. In addition, manufacturers planning to simplify their purification process may find this method beneficial as a means to maintain a sufficient viral clearance level with fewer purification steps.

Join esteemed speakers Dr. Katherine Bergmann, Manager of Viral Safety and Viral Clearance Services at Eurofins Lancaster Laboratories, Dr. Todd Talarico, Vice President of Manufacturing at Medicago, and Sherri Dolan, Field Marketing Manager, Virus Clearance Technologies at Sartorius Stedim North America for this informative session.

During this presentation you will learn:

  • Design and function of the UVivatec instrument
  • Effectiveness of UV-C for inactivation of a number of different viruses in different virus families
  • Impact of UV-C irradiation on the product
  • How to integrate this technology into a manufacturing process
  • Results from a case study detailing the use of UVC as a solution to viral inactivation when other techniques failed for a virus-like-particle vaccine.

For more information on this webinar or to register, visit:

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Michelle Tran (416) 977-6555 ext 224

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Channel Medsystems Receives Health Canada Approval to Begin Clinical Evaluation of its Innovative Procedure for Heavy Menstrual Bleeding; Hires Mary Edwards as Senior Vice President, Clinical and Regulatory Affairs.
2. Nose Job Expert Dr. Babak Azizzadehs New Article Explains How to Prepare for Rhinoplasty Procedures
3. HerbalGram Article Details Procedures for Choosing a Contract Analytical Lab for Dietary Ingredients
4. Surefire Medicals Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures
5. Kitware to Improve Focused Assessment with Sonography for Trauma (FAST) Procedures
6. Non-Intrusive Black Mold Removal Procedure Released By Former Mold Remediation Specialist, Explains
7. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
8. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
9. 2013-2014 Michael E. DeBakey Journalism Awards Call for Entries - Viral Video
10. FDA, NIH and Genzyme Reveal Their Strategies to Overcome Viral Contamination at the Pathogen Safety Summit
11. Prioritizing lab testing for patients on antiretroviral treatment in resource-constrained settings
Post Your Comments:
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... 2016 Andrew D ... Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... line of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining ... Chicago. The result of a collaboration among several companies with expertise in toolholding, ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
Breaking Biology News(10 mins):